-

Veradigm Announces the Resignation of Board Director Beth Altman Due to Health Reasons

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today announced that on January 28, 2025, Beth Altman stepped down from the Company’s Board of Directors (“Board”) due to health reasons. Her decision to resign was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices. Ms. Altman’s resignation has no impact on the Company’s ongoing restatement of its 2022 financial statements.

Altman has been a valued advisor since 2020 and, as Audit Committee Chair, has been instrumental in helping the Company navigate a challenging period. Following Altman’s resignation, the Board appointed Greg Garrison to the Audit Committee of the Board and as interim Chair of the Audit Committee. Garrison previously served as the Chair of the Audit Committee from May 2016 through June 2022.

“On behalf of the entire Board, I thank Beth for the insight, dedication, and expertise that she brought to Veradigm,” said Greg Garrison, Chairman of the Board. “We are grateful for her valuable contributions and wish her all the best.”

Stockholder Input Welcomed on Board Refreshment

The Board is seeking input from stockholders in identifying highly qualified individuals with significant relevant experience to serve on the Board. Stockholders interested in submitting potential candidates should contact Jenny Gelinas, whose contact information is below.

About Veradigm®

Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. For more information about how Veradigm is fulfilling its mission of Transforming Health, Insightfully, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, Instagram, and YouTube.

© 2025 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or company names are the property of their respective holders, all rights reserved.

Contacts

Investors:
Jenny Gelinas
312-506-1237
jenny.gelinas@veradigm.com

Media:
Concetta Rasiarmos
630-740-3152
concetta.rasiarmos@veradigm.com

Veradigm

OTC Pink:MDRX

Release Versions
Hashtags

Contacts

Investors:
Jenny Gelinas
312-506-1237
jenny.gelinas@veradigm.com

Media:
Concetta Rasiarmos
630-740-3152
concetta.rasiarmos@veradigm.com

More News From Veradigm

Veradigm Launches Health Network Architecture to Level the Playing Field for Independent Practices

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced the availability of the Veradigm Health Network Architecture™ to early adopter customers. Veradigm Health Network Architecture provides independent practices a single real-time view of their clinical, financial, and operational performance and helps close a capability gap that has historically separated independent practices from large health...

Veradigm Survey: Independent Practices Rely on Technology to Stay Independent

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today released findings from a nationally distributed survey of 360 independent practice leaders, conducted in March 2026. The survey respondents resolved to remain independent and are counting on technology as a critical lever to drive practice performance. Technology Is Critical to Support Independent Practice Growth The survey found that despite real and...

Veradigm Receives KLAS 2026 Points of Light Award for Embedding SDOH Data in Provider EHR Workflows

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced that it has been recognized by KLAS in the 2026 Points of Light Award program for a collaborative initiative that embedded payer-derived social determinants of health (SDOH) data directly into provider EHR workflows. The recognition, awarded as part of the KLAS K2 Collaborative, highlights a multi-organization effort involving Veradigm, a nat...
Back to Newsroom